Literature DB >> 11209748

Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.

A D Sniderman1, J Bergeron, J Frohlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11209748      PMCID： PMC80634     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  43 in total

1.  Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.

Authors:  B D Miller; E L Alderman; W L Haskell; J M Fair; R M Krauss
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

Review 2.  The adipocyte, fatty acid trapping, and atherogenesis.

Authors:  A D Sniderman; K Cianflone; P Arner; L K Summers; K N Frayn
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

3.  Persistence of use of lipid-lowering medications: a cross-national study.

Authors:  J Avorn; J Monette; A Lacour; R L Bohn; M Monane; H Mogun; J LeLorier
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

4.  The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.

Authors:  P Alaupovic; J D Fesmire; D Hunnighake; M Domanski; S Forman; G L Knatterud; J Forrester; J A Herd; B Hoogwerf; L Campeau; F L Gobel
Journal:  Atherosclerosis       Date:  1999-10       Impact factor: 5.162

5.  LDL size and risk of coronary heart disease in elderly men and women.

Authors:  L Mykkänen; J Kuusisto; S M Haffner; M Laakso; M A Austin
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

6.  Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Authors:  A M Gotto; E Whitney; E A Stein; D R Shapiro; M Clearfield; S Weis; J Y Jou; A Langendörfer; P A Beere; D J Watson; J R Downs; J S de Cani
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

7.  Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes.

Authors:  S F O'Brien; G F Watts; D A Playford; V Burke; D N O'Neal; J D Best
Journal:  Diabet Med       Date:  1997-11       Impact factor: 4.359

8.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Authors:  B Lamarche; A Tchernof; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

9.  Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.

Authors:  S Väisänen; M W Baumstark; I Penttilä; C Bouchard; P Halonen; T Rankinen; A Berg; R Rauramaa
Journal:  Thromb Haemost       Date:  1997-12       Impact factor: 5.249

10.  Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans.

Authors:  V Anber; B A Griffin; M McConnell; C J Packard; J Shepherd
Journal:  Atherosclerosis       Date:  1996-08-02       Impact factor: 5.162
View more
  10 in total

1.  Common problems in the management of hypertriglyceridemia.

Authors:  Michelle A Fung; Jiri J Frohlich
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

Review 2.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

Review 3. 

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2019-06       Impact factor: 3.275

Review 4.  Normal-weight central obesity: Unique hazard of the toxic waist.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2019-06       Impact factor: 3.275

Review 5.  Integrating Advanced Lipid Testing and Biomarkers in Assessment and Treatment.

Authors:  Alexandra Vaio Sykes; Neeja Patel; Danielle Lee; Pam R Taub
Journal:  Curr Cardiol Rep       Date:  2022-08-24       Impact factor: 3.955

Review 6.  Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

7.  Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease.

Authors:  Ritu Sharma; Mridula Mahajan; Ravi Kant
Journal:  Indian J Clin Biochem       Date:  2004-01

Review 8.  Dysfunctional high-density lipoprotein.

Authors:  Hong Feng; Xiang-An Li
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

9.  Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.

Authors:  William Insull; Peter P Toth; H Robert Superko; Roopal B Thakkar; Scott Krause; Ping Jiang; Rhea A Parreno; Robert J Padley
Journal:  Vasc Health Risk Manag       Date:  2010-11-24

10.  Nutrient patterns are associated with discordant apoB and LDL: a population-based analysis.

Authors:  Mohsen Mazidi; Richard J Webb; Elena S George; Niloofar Shekoohi; Julie A Lovegrove; Ian G Davies
Journal:  Br J Nutr       Date:  2021-09-15       Impact factor: 4.125
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.